AXQ Capital LP Has $712,000 Stock Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

AXQ Capital LP lowered its position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 26.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 11,098 shares of the company’s stock after selling 3,994 shares during the quarter. AXQ Capital LP’s holdings in Ryan Specialty were worth $712,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. JPMorgan Chase & Co. boosted its holdings in Ryan Specialty by 107.5% during the third quarter. JPMorgan Chase & Co. now owns 459,464 shares of the company’s stock worth $30,504,000 after purchasing an additional 238,064 shares during the last quarter. Bar Harbor Wealth Management raised its holdings in Ryan Specialty by 5.9% during the fourth quarter. Bar Harbor Wealth Management now owns 168,871 shares of the company’s stock worth $10,835,000 after acquiring an additional 9,482 shares in the last quarter. Barclays PLC boosted its position in Ryan Specialty by 1.1% during the third quarter. Barclays PLC now owns 1,641,743 shares of the company’s stock valued at $108,994,000 after purchasing an additional 17,267 shares during the last quarter. Charles Schwab Investment Management Inc. grew its stake in Ryan Specialty by 43.9% in the third quarter. Charles Schwab Investment Management Inc. now owns 938,187 shares of the company’s stock valued at $62,286,000 after purchasing an additional 286,380 shares in the last quarter. Finally, Teachers Retirement System of The State of Kentucky increased its position in shares of Ryan Specialty by 51.5% during the 3rd quarter. Teachers Retirement System of The State of Kentucky now owns 30,760 shares of the company’s stock worth $2,042,000 after purchasing an additional 10,460 shares during the last quarter. 84.82% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

RYAN has been the topic of a number of recent analyst reports. Keefe, Bruyette & Woods lowered their target price on shares of Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating on the stock in a report on Friday, February 21st. Wells Fargo & Company increased their price target on shares of Ryan Specialty from $64.00 to $69.00 and gave the company an “equal weight” rating in a report on Friday, February 21st. Royal Bank of Canada reduced their price objective on Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating for the company in a report on Friday, February 21st. UBS Group increased their target price on Ryan Specialty from $82.00 to $84.00 and gave the stock a “buy” rating in a research note on Wednesday, February 26th. Finally, Morgan Stanley started coverage on Ryan Specialty in a research note on Thursday, December 5th. They issued an “overweight” rating and a $90.00 price target for the company. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $75.27.

Ryan Specialty Stock Performance

RYAN opened at $71.13 on Friday. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. Ryan Specialty Holdings, Inc. has a 52-week low of $48.48 and a 52-week high of $75.97. The firm has a market cap of $18.63 billion, a P/E ratio of 103.09, a price-to-earnings-growth ratio of 1.19 and a beta of 0.71. The business’s fifty day moving average is $68.11 and its 200-day moving average is $67.98.

Ryan Specialty (NYSE:RYAN) last announced its quarterly earnings data on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.02). Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The firm had revenue of $663.53 million for the quarter, compared to analyst estimates of $658.80 million. Sell-side analysts expect that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Tuesday, March 4th were paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 0.67%. This is a boost from Ryan Specialty’s previous quarterly dividend of $0.11. The ex-dividend date of this dividend was Tuesday, March 4th. Ryan Specialty’s dividend payout ratio (DPR) is 69.57%.

Insider Buying and Selling at Ryan Specialty

In other Ryan Specialty news, Director Nicholas Dominic Cortezi sold 35,000 shares of the business’s stock in a transaction dated Wednesday, January 15th. The stock was sold at an average price of $65.99, for a total transaction of $2,309,650.00. Following the completion of the transaction, the director now owns 35,609 shares of the company’s stock, valued at approximately $2,349,837.91. The trade was a 49.57 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Brendan Martin Mulshine sold 30,000 shares of the firm’s stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The disclosure for this sale can be found here. Insiders sold a total of 241,360 shares of company stock worth $16,006,428 over the last three months. Corporate insiders own 11.10% of the company’s stock.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.